30 Years of Evidence
Join the experts’ corner
Featured Content
SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial
Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy via Helical TomoTherapy versus Conventional Radiotherapy Combined with Concurrent Chemotherapy for Patients with Unresectable
Stage III NSCLC
Feasibility of SBRT with CyberKnife in the Scenario of Lung Metastases Re-RT: Monoinstitutional Experience
Stereotactic Radiosurgery for Recurrent Medulloblastoma in Pediatric and Adult Patients: A Single-Institution Experience
Amirhossein Akhavan-Sigari et al. | RSS | 2024
Stereotactic Radiosurgery for Ependymoma in Pediatric and Adult Patients: A Single-Institution Experience
Amirhossein Akhavan-Sigari et al. | RSS | 2024
Stereotactic Radiosurgery for Cranial and Spinal Hemangioblastomas: A Single-Institution Retrospective Series
Amirhossein Akhavan-Sigari et al. | RSS | 2024
Stereotactic Radiosurgery and Radiotherapy for Brainstem Metastases: An International Multicenter Analysis
Felix Ehret et al. | RSS | 2024
Retreatment for Resistant or Recurrent Pain in Trigeminal Neuralgia Using Frameless LINAC Radiosurgery
Pantaleo Romanelli et al. | RSS | 2024
Preliminary Efficacy and Safety of CyberKnife Radiosurgery in TPIT-linage PitNETs: A Retrospective Study
Shen Yue et al. | RSS | 2024
Health-Related Quality of Life Following Robotic Stereotactic Body Radiation Therapy for High-Risk Prostate Cancer
Vaibhav Sharma et al. | RSS | 2024
Acute Toxicity Following PSMA-Directed Focal Salvage Robotic SBRT for Local Recurrences Following Prior Robotic Prostate SBRT
Zachary Wilson et al | RSS | 2024
Hypofractionated Stereotactic Irradiation for Optic Nerve Glioma
Zagirov RI, Trunin YY, Serova NK, Pronin IN, Antipina NA, Golanov AV | Zh Vopr Neirokhir Im | 2022
Every Other Day Stereotactic Radiation Therapy for the Treatment of Uveal Melanoma Decreases Toxicity
Yazici G, Kiratli H, Ozyigit G, Sari SY, Elmali A, Yilmaz MT, Koc I, Deliktas O, Gumeler E, Cengiz M, Zorlu F. | Radiother Oncol
Robotic CyberKnife Radiosurgery for the Treatment of Choroidal and Ciliary Body Melanoma
Liegl R, Schmelter V, Fuerweger C, Ehret F, Priglinger S, Muacevic A, Foerster P | AM J Opthalmol | 2023
The Impact of Robotic Fractionated Radiotherapy for Benign Tumors of Parasellar Region on the Eye Structure and Function
Orski M, Tarnawski R, Wylęgała E, Tarnawska D | J Clin Med | 2023
Risk-adapted Stereotactic Body Radiotherapy for Patients with Cervical Spinal Metastases
Wang HH, Tian SS, Yang JM, Sun BS, Chen Y, Song YC, Dong Y, Wang JS, Yuan ZY, Cui YL, Meng MB | Cancer Sci
Conventionally Fractionated Radiotherapy Versus CyberKnife Hypofractionated Radiotherapy for Painful Vertebral Haemangiomas – A Randomized Clinical Trial
Miszczyk M, Napieralska A, Woźniak G, Kraszkiewicz M, Gola M, Kalemba M, Głowacki G, Tomasik B, Kocot-Kępska M, Miszczyk L. | Radiother Oncol | 2022
EBUS-guided Fiducial Placement for SBRT in Mediastinal Nodal Oligometastases
Ilaria Morelli et al. | Abstract 1442 | ESTRO | 2024
CyberKnife and Gamma Knife-based SRT for Head and Neck Paragangliomas: A Single-Center Experience
Viola Salvestrini et al. | Abstract 1906 | ESTRO | 2024
Stereotactic Radiosurgery for Intracranial Meningiomas in Elderly Patients: A Retrospective Analysis
Carolin Senger et al. | Abstract 2074 | ESTRO | 2024
Evaluation of Recurrence Patterns after Postoperative Radiosurgery for Brain Metastases
Luca Visani et al. | Abstract 1772 | ESTRO | 2024
Pattern of Recurrence after Fractionated Stereotactic Body Reirradiation in Glioblastoma Recurrence
Agathe Margulies et al. | Abstract 671 | ESTRO | 2024
CYBERNEO Trial: Update of Results at 14 Years of Follow-up
Syrine Ben Dhia et al. | Abstract 413 | ESTRO | 2024
Acute Toxicity from PACE-C Comparing Stereotactic Body Radiotherapy (SBRT) with Moderate Hypofractionation (MHRT)
Alison Tree et al. | Abstract 3395 | ESTRO | 2024
Reappraising Prognostic Factors after SRS/FSRT of Brain Metastases in the era of Targeted Therapies
Christoph A Fink et al. | Abstract 1044 | ESTRO | 2024